Newly Developed Drugs for Alzheimer's Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 20636
Special Issue Editors
Interests: toxins; drug design and development; antidotes for pesticide and nerve agent intoxications; Alzheimer’s disease; detergents as disinfectants, decontamination means; nanotechnology; health economics and pharmacoeconomics
Special Issues, Collections and Topics in MDPI journals
Interests: brain damage; neurology; Alzheimer’s disease
Special Issues, Collections and Topics in MDPI journals
Interests: Alzheimer’s disease; antiaging drugs; nerve agent antidotes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Searching for novel drugs for the treatment of Alzheimer’s disease (AD) has become a main task of current developed societies. There novel drug candidates were/are and will be designed, synthesized and tested in many parts of the world. Despite tremendous advances in the understanding of many aspects of AD pathogenesis, there are no proven disease-modifying therapies, and the only available ones are minimally effective symptomatic therapies.
AD is associated with an enzyme acetylcholinesterase (AChE), which is a target for the development of novel drug candidates for these diseases.
In this Special Issue of International Journal of Molecular Sciences, we would like to discuss all chemico-biological aspects are behind Alzheimer’s disease, and related diseases.
Prof. Dr. Kamil Kuca
Dr. Martin Valis
Dr. Eugenie Nepovimova
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- alzheimer’s disease
- drug development
- therapy
- treatment
- biomarkers
- pathophysiology
- mechanism
- novel drugs
- preclinical
- drug candidate
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.